Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Longevity Health Holdings, Inc. (XAGE : NSDQ)
 
 • Company Description   
Longevity Health Holdings Inc. operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Longevity Health Holdings Inc., formerly known as Carmell Corporation, is based in Pittsburgh, Pennsylvania.

Number of Employees: 15

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.44 Daily Weekly Monthly
20 Day Moving Average: 56,876 shares
Shares Outstanding: 1.00 (millions)
Market Capitalization: $2.45 (millions)
Beta: 0.49
52 Week High: $59.40
52 Week Low: $2.20
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -10.62% -14.59%
12 Week -34.79% -44.30%
Year To Date -70.89% -72.73%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2403 Sidney Street Suite 300
-
Pittsburgh,PA 15203
USA
ph: 919-313-9633
fax: -
None http://www.carmellcorp.com
 
 • General Corporate Information   
Officers
Rajiv Shukla - Chief Executive Officer and Chairman
Bryan J. Cassaday - Chief Financial Officer
Scott Frisch - Director
Kathryn Gregory - Director
Gilles Spenlehauer - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: CONSM PD-MISC DIS
Sector: Consumer Discretionary
CUSIP: 142922129
SIC: 2840
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/13/25
Share - Related Items
Shares Outstanding: 1.00
Most Recent Split Date: 5.00 (0.03:1)
Beta: 0.49
Market Capitalization: $2.45 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/13/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 4.37
EPS Growth
vs. Year Ago Period: 68.36%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 2,817.79%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -280.07
12/31/24 - -281.56
Current Ratio
06/30/25 - -
03/31/25 - 0.42
12/31/24 - 0.16
Quick Ratio
06/30/25 - -
03/31/25 - 0.21
12/31/24 - 0.14
Operating Margin
06/30/25 - -
03/31/25 - -1,534.94
12/31/24 - -
Net Margin
06/30/25 - -
03/31/25 - -1,535.11
12/31/24 - -
Pre-Tax Margin
06/30/25 - -
03/31/25 - -1,552.42
12/31/24 - -21,360.15
Book Value
06/30/25 - -
03/31/25 - -3.79
12/31/24 - -6.77
Inventory Turnover
06/30/25 - -
03/31/25 - 0.58
12/31/24 - 0.08
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - -
 

Powered by Zacks Investment Research ©